Clinical trial / 2001
A low-fat, flaxseed-supplemented diet altered hormonal levels and tumor biology in prostate cancer.
Twenty-five men awaiting prostatectomy followed a low-fat diet supplemented with 30 g/day of flaxseed for an average of 34 days. Participants had significant reductions in total cholesterol (from 201 to 174 mg/dL), total testosterone (from 422 to 360 ng/dL), and free androgen index (from 36.3% to 29.3%; all p < 0.05). Compared with historical controls, dietary treatment was linked to lower tumor proliferation (5.0 vs. 7.4; p = 0.05) and significantly altered apoptotic indices (p = 0.01), with no significant change in overall PSA.
- Study type
- Controlled clinical trial (single-arm intervention with historical controls)
- Who was studied
- 25 men with prostate cancer awaiting surgery
- What was measured
- Serum hormones, prostate-specific antigen, and tumor cell proliferation and apoptosis
THE PAPER
Pilot study of dietary fat restriction and flaxseed supplementation in men with prostate cancer before surgery: exploring the effects on hormonal levels, prostate-specific antigen, and histopathologic features.
Demark-Wahnefried W, Price DT, Polascik TJ, Robertson CN, Anderson EE, Paulson DF, Walther PJ, Gannon M, Vollmer RT. Urology, 2001.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.